0VAG Stock Overview
Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0VAG from our risk checks.
Novanta Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$157.44 |
| 52 Week High | US$185.21 |
| 52 Week Low | US$111.91 |
| Beta | 1.33 |
| 1 Month Change | -8.04% |
| 3 Month Change | 1.11% |
| 1 Year Change | 0.51% |
| 3 Year Change | 17.60% |
| 5 Year Change | 77.14% |
| Change since IPO | 163.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0VAG | GB Electronic | GB Market | |
|---|---|---|---|
| 7D | -4.6% | -2.1% | -0.7% |
| 1Y | 0.5% | -5.6% | -1.8% |
Return vs Industry: 0VAG exceeded the UK Electronic industry which returned -5% over the past year.
Return vs Market: 0VAG exceeded the UK Market which returned -2.4% over the past year.
Price Volatility
| 0VAG volatility | |
|---|---|
| 0VAG Average Weekly Movement | 5.7% |
| Electronic Industry Average Movement | 4.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0VAG has not had significant price volatility in the past 3 months.
Volatility Over Time: 0VAG's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 2,900 | Matthijs Glastra | www.novanta.com |
Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
Novanta Inc. Fundamentals Summary
| 0VAG fundamental statistics | |
|---|---|
| Market cap | US$5.55b |
| Earnings (TTM) | US$72.88m |
| Revenue (TTM) | US$881.66m |
76.1x
P/E Ratio6.3x
P/S RatioIs 0VAG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0VAG income statement (TTM) | |
|---|---|
| Revenue | US$881.66m |
| Cost of Revenue | US$486.77m |
| Gross Profit | US$394.90m |
| Other Expenses | US$322.02m |
| Earnings | US$72.88m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | 2.03 |
| Gross Margin | 44.79% |
| Net Profit Margin | 8.27% |
| Debt/Equity Ratio | 52.6% |
How did 0VAG perform over the long term?
See historical performance and comparison